D’Amico, F;
Rehill, A;
Knapp, M;
Aguirre, E;
Donovan, H;
Hoare, Z;
Hoe, JM;
... Orrell, M; + view all
(2015)
Maintenance cognitive stimulation therapy: an economic evaluation within a randomised controlled trial.
Journal of the American Medical Directors Association
, 16
(1)
pp. 63-70.
10.1016/j.jamda.2014.10.020.
Preview |
Text
Spector_1-s2.0-S1525861014006987-main.pdf - Published Version Download (445kB) | Preview |
Abstract
Background: Cognitive Stimulation Therapy (CST) is effective and cost-effective for people with mild-to-moderate dementia when delivered bi-weekly over seven weeks. Aims: To examine whether longer-term (maintenance) CST is cost-effective when added to usual care. Methods: Cost-effectiveness analysis within multicentre, single-blind, pragmatic randomised controlled trial; subgroup analysis for people taking acetylcholinesterase inhibitors (ACHEIs). 236 participants with mild-tomoderate dementia received CST for seven weeks. They were randomised to either weekly maintenance CST added to usual care or usual care alone for 24 weeks. Results: Although outcome gains were modest over 6 months, maintenance CST appeared cost-effective when looking at self-rated quality of life as primary outcome, and cognition (MMSE) and proxy-rated quality-adjusted life years as secondary outcomes. CST in combination with ACHEIs offered costeffectiveness gains when outcome was measured as cognition. Conclusions: Continuation of CST is likely to be cost-effective for people with mild-tomoderate dementia. Trial registration: Current controlled trials ISRCTN26286067
Archive Staff Only
 |
View Item |
